Selected article for: "HRV replication and virus replication"

Author: Grazia Martina, Maria; Vicenti, Ilaria; Bauer, Lisa; Crespan, Emmanuele; Rango, Enrico; Boccuto, Adele; Olivieri, Noemi; Incerti, Matteo; Zwaagstra, Marleen; Allodi, Marika; Bertoni, Simona; Dreassi, Elena; Zazzi, Maurizio; van Kuppeveld, Frank J. M.; Maga, Giovanni; Radi, Marco
Title: Bithiazole Inhibitors of Phosphatidylinositol 4‐Kinase (PI4KIIIβ) as Broad‐Spectrum Antivirals Blocking the Replication of SARS‐CoV‐2, Zika Virus, and Human Rhinoviruses
  • Cord-id: j11i1yzl
  • Document date: 2021_9_7
  • ID: j11i1yzl
    Snippet: Over half a century since the description of the first antiviral drug, “old” re‐emerging viruses and “new” emerging viruses still represent a serious threat to global health. Their high mutation rate and rapid selection of resistance toward common antiviral drugs, together with the increasing number of co‐infections, make the war against viruses quite challenging. Herein we report a host‐targeted approach, based on the inhibition of the lipid kinase PI4KIIIβ, as a promising strate
    Document: Over half a century since the description of the first antiviral drug, “old” re‐emerging viruses and “new” emerging viruses still represent a serious threat to global health. Their high mutation rate and rapid selection of resistance toward common antiviral drugs, together with the increasing number of co‐infections, make the war against viruses quite challenging. Herein we report a host‐targeted approach, based on the inhibition of the lipid kinase PI4KIIIβ, as a promising strategy for inhibiting the replication of multiple viruses hijacking this protein. We show that bithiazole inhibitors of PI4KIIIβ block the replication of human rhinoviruses (hRV), Zika virus (ZIKV) and SARS‐CoV‐2 at low micromolar and sub‐micromolar concentrations. However, while the anti‐hRV/ZIKV activity can be directly linked to PI4KIIIβ inhibition, the role of PI4KIIIβ in SARS‐CoV‐2 entry/replication is debated.

    Search related documents:
    Co phrase search for related documents
    • acute long term toxicity and long term toxicity: 1, 2, 3
    • acute respiratory syndrome and additional result: 1, 2, 3, 4, 5
    • acute respiratory syndrome and additional target: 1, 2, 3, 4, 5
    • acute respiratory syndrome and adme property: 1, 2, 3, 4, 5
    • acute respiratory syndrome and long term toxicity: 1, 2
    • acute respiratory syndrome and low affinity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute respiratory syndrome and low micromolar concentration: 1
    • acute respiratory syndrome and low toxicity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute toxicity and long term toxicity: 1, 2, 3, 4, 5, 6
    • acute toxicity and low toxicity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • long term toxicity and low toxicity: 1, 2, 3, 4, 5, 6
    • low affinity and lung infection: 1, 2